146 related articles for article (PubMed ID: 11904462)
1. Topical mitomycin C and radiation induce conjunctival DNA-polyploidy.
Cartsburg O; Kallen C; Hillenkamp J; Sundmacher R; Pomjanski N; Böcking A
Anal Cell Pathol; 2001; 23(2):65-74. PubMed ID: 11904462
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
[TBL] [Abstract][Full Text] [Related]
3. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
4. Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva.
Nadjari B; Kersten A; Ross B; Motherby H; Krallmann R; Sundmacher R; Böcking A
Anal Quant Cytol Histol; 1999 Oct; 21(5):387-96. PubMed ID: 10560521
[TBL] [Abstract][Full Text] [Related]
5. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
Shields CL; Naseripour M; Shields JA
Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
[TBL] [Abstract][Full Text] [Related]
6. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
Salomão DR; Mathers WD; Sutphin JE; Cuevas K; Folberg R
Ophthalmology; 1999 Sep; 106(9):1756-60; discussion 1761. PubMed ID: 10485547
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
Ditta LC; Shildkrot Y; Wilson MW
Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
[TBL] [Abstract][Full Text] [Related]
8. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
[TBL] [Abstract][Full Text] [Related]
9. [Topical Mitomycin C as a therapy of conjunctival tumours].
Schallenberg M; Niederdräing N; Steuhl KP; Meller D
Ophthalmologe; 2008 Aug; 105(8):777-84. PubMed ID: 18618124
[TBL] [Abstract][Full Text] [Related]
10. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
Finger PT; Czechonska G; Liarikos S
Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
[TBL] [Abstract][Full Text] [Related]
11. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
Akpek EK; Ertoy D; Kalayci D; Hasiripi H
Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
[TBL] [Abstract][Full Text] [Related]
12. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
[TBL] [Abstract][Full Text] [Related]
13. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
Sacu S; Ségur-Eltz N; Horvat R; Lukas JR; Zehetmayer M
Am J Ophthalmol; 2003 Aug; 136(2):375-7. PubMed ID: 12888073
[TBL] [Abstract][Full Text] [Related]
14. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
Werschnik C; Lommatzsch PK
Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
[TBL] [Abstract][Full Text] [Related]
15. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
Wilson MW; Hungerford JL; George SM; Madreperla SA
Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
[TBL] [Abstract][Full Text] [Related]
16. Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma.
Frucht-Pery J; Rozenman Y; Pe'er J
Ophthalmology; 2002 Mar; 109(3):548-52. PubMed ID: 11874760
[TBL] [Abstract][Full Text] [Related]
17. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
[TBL] [Abstract][Full Text] [Related]
18. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
Khong JJ; Muecke J
Br J Ophthalmol; 2006 Jul; 90(7):819-22. PubMed ID: 16672325
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
[TBL] [Abstract][Full Text] [Related]
20. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
Kurli M; Finger PT
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
